Patents
More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
10/2007
10/10/2007CN101049502A Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
10/04/2007US20070231382 Pharmaceutical composition
10/03/2007EP1840117A1 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
10/03/2007EP1838257A1 Component for forming a seal around an opening in the skin
10/03/2007EP1490361B1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/03/2007CN101045039A Dosage form for treatment of diabetes mellitus
10/03/2007CN100340559C Nitrogen containing heterobicycles as factor XA inhibitors
10/02/2007CA2387357C Derivatives of pyrazolo[4,3-d]pyrimidin-7-ones which inhibit cyclic guanosine 3',5'-monophosphate phosphodiesterase
09/2007
09/26/2007EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
09/26/2007EP1363650B1 Composition containing pimenta extract in aquatic animal treatment methods
09/26/2007CN100339130C 疫苗 Vaccine
09/18/2007US7271156 Immunostimulatory nucleic acids
09/13/2007US20070213344 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/13/2007US20070213343 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/13/2007US20070212421 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/12/2007EP1832279A2 A process for the preparation of suspensions of drug particles for inhalation delivery
09/05/2007CN101029022A Process for the preparation of 4-phenoxy quinoline derivatives
09/05/2007CN101028519A Pharmaceutical composition for treating immune diseases
09/05/2007CN100335464C Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
09/04/2007US7265130 anti-obestic activity; Neuropeptide Y antagonist
09/04/2007US7265119 For therapy of nicotine dependency
08/2007
08/30/2007US20070203184 Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them
08/30/2007US20070203152 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/30/2007US20070203151 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/30/2007US20070203150 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/30/2007US20070202181 Low hygroscopic aripipazole drug substance and processes for the preparation thereof
08/30/2007US20070202170 Dual-release compositions of a cyclooxygenase-2 inhibitor
08/30/2007US20070202133 BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
08/28/2007US7262203 For therapy of hyperproliferative diseases such as cancer or retinopathy; pazopanib and salts
08/23/2007US20070197601 Use of N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives in therapy
08/22/2007EP1448523B1 Heterocyclic compounds and methods of use
08/21/2007US7258861 Peptides derived from the region of human TNF- alpha from Ser100 to Glu116 to treat pulmonary oedema.
08/15/2007EP1368028B1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
08/14/2007US7256213 Taxanes having a C10 carbonate substituent
08/09/2007US20070185143 Anticarcinogenic agents, antimetastasis agents; angiogenesis inhibitors; transplant rejection
08/08/2007EP1423124B1 Lyophilized formulation comprising olanzapine
08/07/2007US7253203 Indoline derivatives
08/02/2007US20070179179 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol
08/01/2007CN1329389C Novel compounds and their use
07/2007
07/31/2007US7250419 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
07/31/2007US7250165 Anti-TNF antibodies, compositions, methods and uses
07/25/2007EP1810679A2 Controlled release oxycodone compositions
07/24/2007US7247633 Pyrimidine compounds and their use
07/18/2007EP1373224B1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
07/18/2007EP1150678B1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy
07/18/2007CN100999501A Process for the preparation of 2-methyl piperazine derivatives
07/17/2007US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy
07/12/2007US20070161666 Pyrrolo[2,3-d]pyrimidine compounds
07/11/2007EP1175398B1 Indoline derivatives as progesterone antagonists
07/11/2007CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
07/10/2007US7241782 Modifications are prepared by subjecting an alkaline solution of torasemide to a rapid acidification with inorganic or organic acids at 0 to 35 degrees C.
07/10/2007CA2396814C Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical compositions containing them
07/04/2007CN1990474A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
07/04/2007CN1990469A Pyrrolidines as dipeptidyl peptidase inhibitors
07/04/2007CN1990468A Pyrrolidines as dipeptidyl peptidase inhibitors
07/03/2007US7238723 Indole derivatives
06/2007
06/27/2007EP1801106A2 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
06/21/2007US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ
06/20/2007CN1982308A Substituted pyrazoles
06/20/2007CN1321996C Process for preparing 2-iminopyrrolidine derivatives
06/19/2007US7232823 such as 1-[2-(2-chloro-phenyl)-3-(4-fluoro-phenyl)-2H-pyrazolo[3,4-d]pyridazin-7-yl]-4-isopropylamino-piperidine-4-carboxylic acid amide; for treatment of eating disorders and psychological disorders
06/14/2007US20070135502 Heterocyclic compounds and methods of use
06/13/2007CN1980916A Chemokine receptor binding heterocyclic compounds
06/13/2007CN1321110C 4-piperazinylindole derivatives with 5-HT6 receptor affinity
06/12/2007US7230013 Administering taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions for inhibiting tumor growth
06/12/2007US7229997 1-(pyridin-2-yl)-piperazine derivatives; serotonin receptor antagonists
06/07/2007US20070129312 Convalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
06/06/2007CN1974570A Fused pyrrolocarbazoles against inflammation
06/06/2007CN1319532C Use of N-(indolecarbonyl-)piperazine derivatives
06/05/2007US7226944 As antitumor agent
05/2007
05/30/2007EP1790642A1 Biologically active methylene blue derivatives
05/29/2007US7223789 Heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
05/24/2007US20070117799 Oxabispidine compounds useful in the treatment of cardiac arrhythmias
05/16/2007CN1961880A Cancer treatment.
05/16/2007CN1315862C Methods and compositions for treating flaviviruses and pestiviruses
05/16/2007CN1315809C Quinoline derivatives and their use as 5-HT6 ligands
05/15/2007US7217738 β2-adrenergic receptor agonists
05/15/2007CA2366829C Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
05/10/2007US20070105933 Amino alcohol compounds
05/10/2007US20070105855 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
05/10/2007US20070105854 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
05/09/2007EP1597238B1 Hiv replication inhibiting pyrimidines and triazines
05/09/2007EP1446131B1 Use of specific dose of fondaparinux sodium for the treatment of acs
05/08/2007US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
05/03/2007US20070100001 Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof
05/02/2007EP1499589B1 Derivatives of n-phenyl(piperidin-2-yl)methyl benzamide, the preparation method thereof and application of same in therapeutics
05/02/2007CN1313465C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
05/01/2007USRE39608 Substituted benzimidazoles and their use as PARP inhibitors
05/01/2007US7211648 Gag-peptide complex
04/2007
04/25/2007EP1776962A1 Vaccine
04/25/2007CN1952119A Blood cell production via activation of the hemoglobin scavenger receptor
04/25/2007CN1951371A Immediate release tablet
04/25/2007CN1312137C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
04/24/2007USRE39585 Administering streptococcus thermophilus in admixture withLactobacillus brevis, Lactobacillus acidophilus, Lactobacillus plantarum, Bifidobacterium infantis, Bifidobacterium longum or Bifidobacterium breve
04/18/2007EP1774969A2 Controlled release oxycodone compositions
04/18/2007EP1476162B1 Controlled synthesis of ziprasidone
04/18/2007CN1310872C Mono- and disubstituted 3-propyl gamma-aminobutyric acids
04/17/2007US7205287 Platinum complexes having antitumor activity
04/11/2007EP1458689B1 Aryloxyphenyl and arylsulfanylphenyl derivatives
04/05/2007US20070077260 Vaccines for mycoplasma bovis and methods of use
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 32